At a glance
- Originator Merck Sharp & Dohme
- Class Antipsychotics
- Mechanism of Action Dopamine D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 26 Jun 2001 No-Development-Reported for Schizophrenia in USA (Unknown route)
- 10 Jul 1997 Preclinical development for Schizophrenia in USA (Unknown route)